State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China.
Blood Purification Center, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Int J Nanomedicine. 2023 May 15;18:2589-2621. doi: 10.2147/IJN.S402891. eCollection 2023.
Zein is a type of prolamine protein that is derived from corn, and it has been recognized by the US FDA as one of the safest biological materials available. Zein possesses valuable characteristics that have made it a popular choice for the preparation of drug carriers, which can be administered through various routes to improve the therapeutic effect of antitumor drugs. Additionally, zein contains free hydroxyl and amino groups that offer numerous modification sites, enabling it to be hybridized with other materials to create functionalized drug delivery systems. However, despite its potential, the clinical translation of drug-loaded zein-based carriers remains challenging due to insufficient basic research and relatively strong hydrophobicity. In this paper, we aim to systematically introduce the main interactions between loaded drugs and zein, administration routes, and the functionalization of zein-based antitumor drug delivery systems, in order to demonstrate its development potential and promote their further application. We also provide perspectives and future directions for this promising area of research.
玉米醇溶蛋白是一种来源于玉米的醇溶蛋白,它已被美国 FDA 认可为可用的最安全的生物材料之一。玉米醇溶蛋白具有有价值的特性,使其成为制备药物载体的热门选择,通过各种途径给药可以提高抗肿瘤药物的治疗效果。此外,玉米醇溶蛋白含有游离的羟基和氨基,提供了许多修饰位点,使其能够与其他材料杂交,形成功能化的药物传递系统。然而,尽管具有潜力,但载药玉米醇溶蛋白载体的临床转化仍然具有挑战性,这是由于基础研究不足和相对较强的疏水性所致。本文旨在系统地介绍载药与玉米醇溶蛋白之间的主要相互作用、给药途径以及基于玉米醇溶蛋白的抗肿瘤药物传递系统的功能化,以展示其发展潜力并促进其进一步应用。我们还为这一有前途的研究领域提供了观点和未来方向。